Patents by Inventor Ralf Roeddiger

Ralf Roeddiger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF SEPRASE FOR DIFFERENTIAL DIAGNOSIS OF ACUTE DYSPNEA
    Publication number: 20160018411
    Abstract: The present invention relates to a method for differentiating in a patient who suffers from acute shortness of breath (acute dyspnea) between pulmonary disease and cardiac disease. The method is based on measuring the levels of seprase and of a cardiac marker in a sample from said patient. Further envisaged are kits and devices adapted to carry out the method of the present invention.
    Type: Application
    Filed: March 5, 2015
    Publication date: January 21, 2016
    Inventors: Christoph Ehret, Johann Karl, Ralf Roeddiger, Wolfgang Rollinger, Magdalena Swiatek-de Lange
  • MEASUREMENT OF C-TERMINAL proSP-B
    Publication number: 20140017815
    Abstract: In vitro methods for obtaining an indication of damage in the broncheoalveolar compartment of the lung comprising, measuring C-terminal proSP-B in a bodily fluid sample and comparing the level measured to a reference level of C-terminal proSP-B, wherein an increased level of C-terminal proSP-B is indicative of damage in the broncheoalveolar compartment of the lung.
    Type: Application
    Filed: September 20, 2013
    Publication date: January 16, 2014
    Applicant: ROCHE DIAGNOSTICS OPERATIONS, INC.
    Inventors: Volker Klemt, Christine Boehm, Andreas Gallusser, Ralf Roeddiger
  • Treatment of disturbances of iron distribution
    Patent number: 7459436
    Abstract: The present invention relates to the use of erythropoietin for the treatment of disturbances of iron distribution in heart diseases.
    Type: Grant
    Filed: November 12, 2003
    Date of Patent: December 2, 2008
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Paul Lehmann, Ralf Roeddiger, Ruth Walter-Matsui
  • Treatment of disturbances of iron distribution
    Patent number: 7459435
    Abstract: A method of, and pharmaceutical composition for, treating disturbances of iron distribution in diabetes using erythropoietin are disclosed.
    Type: Grant
    Filed: August 4, 2003
    Date of Patent: December 2, 2008
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Paul Lehmann, Ralf Roeddiger, Ruth Walter-Matsui
  • Method of treating disturbances of iron distribution in inflammatory intestinal diseases
    Patent number: 7459429
    Abstract: The present invention relates to the use of erythropoietin for the treatment of disturbances of iron distribution in chronic inflammatory intestinal diseases.
    Type: Grant
    Filed: December 16, 2004
    Date of Patent: December 2, 2008
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Horst Klima, Paul Lehmann, Ralf Roeddiger, Ruth Walter-Matsui
  • Differential diagnosis with hepcidin
    Patent number: 7416857
    Abstract: The present invention concerns the use of hepcidin as a marker for detecting inflammatory chronic diseases and especially for a differential diagnosis to detect inflammatory chronic diseases and/or non-inflammatory chronic diseases. The present invention also concerns a method for detecting inflammatory chronic diseases, non-inflammatory chronic diseases and/or acute phase reactions comprising the determination of hepcidin.
    Type: Grant
    Filed: October 22, 2004
    Date of Patent: August 26, 2008
    Assignee: Roche Diagnostics Operations Inc.
    Inventors: Paul Lehmann, Ralf Roeddiger
  • Method of treating disturbances of iron distribution in inflammatory intestinal diseases
    Publication number: 20050181986
    Abstract: The present invention relates to the use of erythropoietin for the treatment of disturbances of iron distribution in chronic inflammatory intestinal diseases.
    Type: Application
    Filed: December 16, 2004
    Publication date: August 18, 2005
    Inventors: Horst Klima, Paul Lehmann, Ralf Roeddiger, Ruth Walter-Matsui
  • Differential diagnosis with hepcidin
    Publication number: 20050148025
    Abstract: The present invention concerns the use of hepcidin as a marker for detecting inflammatory chronic diseases and especially for a differential diagnosis to detect inflammatory chronic diseases and/or non-inflammatory chronic diseases. The present invention also concerns a method for detecting inflammatory chronic diseases, non-inflammatory chronic diseases and/or acute phase reactions comprising the determination of hepcidin.
    Type: Application
    Filed: October 22, 2004
    Publication date: July 7, 2005
    Inventors: Paul Lehmann, Ralf Roeddiger
  • Soluble transferrin receptor
    Publication number: 20050136455
    Abstract: The invention concerns a method for detecting coronary syndromes, in particular, coronary artery disease (CAD), using risk markers.
    Type: Application
    Filed: October 22, 2004
    Publication date: June 23, 2005
    Inventors: Paul Lehmann, Ralf Roeddiger
  • Treatment of disturbances of iron distribution
    Publication number: 20040209802
    Abstract: The present invention relates to the use of erythropoietin for the treatment of disturbances of iron distribution in heart diseases.
    Type: Application
    Filed: November 12, 2003
    Publication date: October 21, 2004
    Inventors: Paul Lehmann, Ralf Roeddiger, Ruth Walter-Matsui
  • Treatment of disturbances of iron distribution
    Publication number: 20040110679
    Abstract: A method of, and pharmaceutical composition for, treating disturbances of iron distribution in diabetes using erythropoietin are disclosed.
    Type: Application
    Filed: August 4, 2003
    Publication date: June 10, 2004
    Inventors: Paul Lehmann, Ralf Roeddiger, Ruth Walter-Matsui